Optimization, characterization, comparison of self-assembly VLP of capsid protein L1 in yeast and reverse vaccinology design against human papillomavirus type 52-Reference-Cited by-同舟云学术

Optimization, characterization, comparison of self-assembly VLP of capsid protein L1 in yeast and reverse vaccinology design against human papillomavirus type 52

Published:2023-12 Issue:1 Volume:21 Page:68
ISSN:1687-157X
Container-title:Journal of Genetic Engineering and Biotechnology
language:en
Short-container-title:Journal of Genetic Engineering and Biotechnology

Author:

Firdaus Moh Egy Rahman,Mustopa Apon Zaenal^ORCID,Ekawati Nurlaili,Chairunnisa Sheila,Arifah Rosyida Khusniatul,Hertati Ai,Irawan Shasmita,Prastyowati Anika,Kusumawati Arizah,Nurfatwa Maritsa

Funder

Lembaga Pengelola Dana Pendidikan

DIPA PN Rumah Program Hasil Pengungkapan dan Pemanfaatan Biodiversitas Nusantara OR HL BRIN

DIPA PN Rumah Program Hasil Pengungkapan dan Pemanfaatan Biodiversitas Nusantara OR Hayati dan Lingkungan BRIN

Publisher

Elsevier BV

Subject

Genetics,Biotechnology

Link

https://link.springer.com/content/pdf/10.1186/s43141-023-00514-9.pdf

Reference63 articles.

1. HPV vaccination and the risk of invasive cervical cancer;Lei;N Engl J Med,2020

2. The next generation of HPV vaccines: nonavalent vaccine V503 on the horizon;Chatterjee;Expert Rev Vaccines,2014

3. Production of virus-like particles for vaccines;Fuenmayor;New Biotechnol,2017

4. Human Papillomavirus Vaccines;Markowitz;J Infect Dis,2021

5. Nascimento IP, Leite LCC (2012) Recombinant vaccines and the development of new vaccine strategies. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 45:1102–1111

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The potential use of therapeutics and prophylactic mRNA vaccines in human papillomavirus (HPV);Virology Journal;2024-05-31

2. Reverse engineering protection: A comprehensive survey of reverse vaccinology-based vaccines targeting viral pathogens;Vaccine;2024-04

3. Expression and scale-up production of recombinant human papillomavirus type 52 L1 protein in methylotrophic yeast Hansenula polymorpha;Journal of Genetic Engineering and Biotechnology;2024-03

4. Precise Therapy Using the Selective Endogenous Encapsidation for Cellular Delivery Vector System;Pharmaceutics;2024-02-19

5. Subunit protein-based vaccines;Advanced Vaccination Technologies for Infectious and Chronic Diseases;2024